# Sanofi

Type: Company

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/sanofi
Canonical HTML page: https://gethealthbrief.com/entity/sanofi

## Timeline

- **2026**: Rollout Milestone — Acoziborole enters the final stages of regulatory rollout for endemic regions.
- **2022**: Trial Results — Phase 2/3 clinical trial results for Acoziborole show high efficacy.
- **2018**: Fexinidazole Approval — First all-oral 10-day treatment for sleeping sickness is approved.
- **2009**: Research Begins — DNDi starts screening compounds for a single-dose HAT treatment.

## Recent coverage (4 stories)

### New pill cuts LDL 59%: How Lipfendra could change cholesterol care for millions
2026-07-16 22:00:46 · Sentiment: Strongly positive · Impact: 9/10 · Sources: 132

The FDA approved the first oral PCSK9 inhibitor, Lipfendra, demonstrating a 59% LDL reduction in trials. The pill form removes injection barriers and is priced lower than existing injectables, potentially improving adherence and access for patients with high cholesterol.
Full story: https://gethealthbrief.com/story/lipfendra-oral-pcsk9-lowers-ldl-59-percent-patient-access

### Single-Dose Breakthrough: Acoziborole Signals End of Sleeping Sickness
2026-03-16 21:44:53 · Sentiment: Strongly positive · Impact: 8/10 · Sources: 2

The introduction of Acoziborole, a single-dose oral medication, marks a pivotal shift in the global fight against Human African Trypanosomiasis. This breakthrough treatment simplifies complex therapeutic regimens, potentially enabling the total elimination of the disease by 2030.
Full story: https://gethealthbrief.com/story/acoziborole-sleeping-sickness-elimination-2026

### US Flu Vaccine Effectiveness Drops Below Historical Averages for 2025-26 Season
2026-03-14 23:47:43 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Preliminary CDC data indicates that the 2025-2026 influenza vaccine provided lower-than-expected protection, with effectiveness falling to approximately 32%. The findings highlight a significant mismatch between the vaccine's composition and the dominant H3N2 variant, sparking calls for faster manufacturing platforms.
Full story: https://gethealthbrief.com/story/flu-vaccine-effectiveness-decline-2026

### CDC Issues Travel Advisories for Tourist Hubs Amid Global Polio Resurgence
2026-03-04 18:36:27 · Sentiment: Negative · Impact: 7/10 · Sources: 2

The CDC has issued a series of travel notices for popular international tourist destinations following a spike in polio detections. The move signals a shift in global health security, requiring travelers to verify immunization status and potentially seek adult boosters before departure.
Full story: https://gethealthbrief.com/story/cdc-polio-travel-advisories-2026

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.